Ex vivo activated macrophages myocardial transplantation improve the ventricular remodeling of the infarcted heart induced by ischemia/reperfusion

Abstract

Abstract: Objective To investigate the mechanism of the paracrine effect of phenytoin (PHT) and macrophage in the angiogenesis and ventricular remodeling after myocardial infarction (MI). Method The peritoneal macrophages were adherently cultured, and parts of cultured macrophages were pre-stimulated by PHT. The survival animals induced experimental ischemia-reperfusion (I/R) were randomly distributed into Sham group, control (AMI) group, Phenytoin (PHT) group group, macrophage (MΦ) group, phenytoin pre-stimulating macrophage (MΦ-PHT) group. At the 7th and 28th day after the induction of I/R, histology examination were analyzed including index of expansion, fiber area, arterioles density, capillary density in infarct region and cardiocyte cross-sectional area (CSA) in non-infarct zone. The levels of protein expression of vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF) within infarct region 7 days after MI were determined by Western blot. Result Compared with AMI group, Index of Expansion, fiber area and CSA in non-infarct zone at 28th day were all decreased in PHT group, MΦ group and MΦ-PHT group (P <0.05), while arteriole density in infarct zone had increased (P <0.05). Fiber area of MΦ-PHT group at 28th day was fewer than MΦ group (P <0.05). Compared with MΦ group, capillary density and arteriole density in infarct zone at 7th and 28th day had increasing tendency. The levels of VEGF, bFGF protein expression in infarct zone at 7th day in MΦ-PHT group were more than MΦ group (P <0.05). Conclusion Phenytoin may promote angiogenesis in infarct zone and improve ventricular remodeling after MI through stimulating macrophages, which up-regulate the growth factors involved in the angiogenesis through the paracrine effect.

He LI. Ex vivo activated macrophages myocardial transplantation improve the ventricular remodeling of the infarcted heart induced by ischemia/reperfusion[J]. Basic & Clinical Medicine, 2011, 31(11): 1267-1272.

References

[1] Ertl G, Frantz S. Healing after myocardial infarction[J]. Cardiovasc Res, 2005, 66:22-32. [2] Anstead GM, Hart LM, Sunahara JF, et al. Phenytoin in wound healing[J]. Ann Pharmacother, 1996, 30:768-775. [3] Dill RE, Miller EK, Weil T, et al. Phenytoin increases gene expression for platelet-derived growth factor B chain in macrophages and monocytes[J]. J Periodontol, 1993, 64:169-173. [4] Weihrauch D, Arras M, Zimmermann R, et al. Importance of monocytes/macrophages and fibroblasts for healing of micronecroses in porcine myocardium[J]. Mol Cell Biochem, 1995, 147:13-19. [5] Nakade O, Baylink DJ, Lau KH. Phenytoin at micromolar concentrations is an osteogenic agent for human-mandible-derived bone cells in vitro[J]. J Dent Res, 1995, 74:331-337. [6] Zhou X, Li YM, Ji WJ, et al. Phenytoin can accelerate the healing process after experimental myocardial infarction? [J] Int J Cardiol, 2006, 107:21-29. [7] 李贺,周欣,舒珺,等.骨髓间充质干细胞移植对心肌缺血-再灌注大鼠心肌胶原与血管新生的影响[J].中国动脉硬化杂志.2008,16:813-818. [8] Hochman JS, Choo H. Limitation of myocardial infarct expansion by reperfusion independent of myocardial salvage[J]. Circulation, 1987, 75:299-306. [9] Reffelmann T, Hale SL, Dow JS, et al. No-reflow phenomenon persists long-term after ischemia/reperfusion in the rat and predicts infarct expansion[J]. Circulation, 2003, 108:2911-2917. [10] Tuder RM, Flook BE, Voelkel NF. Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide[J]. J Clin Invest, 1995, 95:1798-1807. [11] Gospodarowicz D. Expression and control of vascular endothelial cells: proliferation and differentiation by fibroblast growth factors[J]. J Invest Dermatol, 1989, 93:39S-47S. [12] Spirito P, Fu YM, Yu ZX, et al. Immunohistochemical localization of basic and acidic fibroblast growth factors in the developing rat heart[J]. Circulation, 1991, 84:322-332. [13] Folkman J, Klagsbrun M. Angiogenic factors[J]. Science, 1987, 235:442-447. [14] Lambert JM, Lopez EF, Lindsey ML. Macrophage roles following myocardial infarction[J]. Int J Cardiol, 2008, 130:147-158. [15] Sunderkotter C, Steinbrink K, Goebeler M, et al. Macrophages and angiogenesis[J]. J Leukoc Biol, 1994, 55:410-422. [16] Ono M, Torisu H, Fukushi J, et al. Biological implications of macrophage infiltration in human tumor angiogenesis[J]. Cancer Chemother Pharmacol, 1999, 43 Suppl:S69-71. [17] Luikart SD, Levay-Young B, Hinkel T, et al. Mactinin treatment promotes wound-healing-associated inflammation in urokinase knockout mice[J]. Wound Repair Regen, 2006, 14:123-128. [18] van Amerongen MJ, Harmsen MC, van Rooijen N, et al. Macrophage depletion impairs wound healing and increases left ventricular remodeling after myocardial injury in mice[J]. Am J Pathol, 2007, 170:818-829. [19] Leor J, Rozen L, Zuloff-Shani A, et al. Ex vivo activated human macrophages improve healing, remodeling, and function of the infarcted heart[J]. Circulation, 2006, 114:I94-100. [20] Maulik N. Angiogenic signal during cardiac repair[J]. Mol Cell Biochem, 2004, 264:13-23. [21] Heymans S, Luttun A, Nuyens D, et al. Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure[J]. Nat Med, 1999, 5:1135-1142. [22] Schaper W, Scholz D. Factors regulating arteriogenesis[J]. Arterioscler Thromb Vasc Biol, 2003, 23:1143-1151. [23] Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications[J]. Circulation, 1990, 81:1161-1172.